Synthetic lethality screens point the way to new cancer drug targets

Nature Reviews Drug Discovery 16, 589 (2017). doi:10.1038/nrd.2017.165 Author: Asher Mullard A resurgence in synthetic lethality screening, enabled by CRISPR gene editing, is unlocking targeted drugs for patients with cancerous loss-of-function mutations.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research